Smell and taste in inflammatory bowel disease.

OBJECTIVE: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. PATIENTS AND METHODS: In total, 59 IBD patients (37 Cr...

Full description

Bibliographic Details
Main Authors: Silke Steinbach, Wolfgang Reindl, Astrid Dempfle, Anna Schuster, Petra Wolf, Walter Hundt, Wolfgang Huber
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3783456?pdf=render
id doaj-527978ea0a144ca6913ca35f07d98a7b
record_format Article
spelling doaj-527978ea0a144ca6913ca35f07d98a7b2020-11-24T21:45:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7345410.1371/journal.pone.0073454Smell and taste in inflammatory bowel disease.Silke SteinbachWolfgang ReindlAstrid DempfleAnna SchusterPetra WolfWalter HundtWolfgang HuberOBJECTIVE: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. PATIENTS AND METHODS: In total, 59 IBD patients (37 Crohn's disease (CD) and 22 ulcerative colitis (UC) patients) were studied using "Sniffin' sticks" and "taste strips" for olfactory and gustatory tests, respectively, and compared to healthy controls and published normative data. RESULTS: Among IBD (CD and UC) patients, the values for odor threshold, but not for odor identification or discrimination, were significantly lower than that of the normative data. Further, these patients showed lower values than the normative taste values and the control group for all tastes, except sour; 57.6% of the IBD patients were hyposmic, while 30.5% were hypogeusic. Subjective self-assessments showed that the patients were not aware of their reduced olfactory/gustatory functions. There were no relevant differences in taste and smell abilities between the CD and UC patients. Disease activity and treatment did not influence the olfactory/gustatory functions. CONCLUSION: IBD (CD and UC) patients exhibited significant reductions in the olfactory and gustatory functions. Therefore, patients should be tested by smell/taste tests, in order to be adequately informed of their olfactory/gustatory functions and provided an understanding of how to overcome their limitations, and thus improve their quality of life.http://europepmc.org/articles/PMC3783456?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Silke Steinbach
Wolfgang Reindl
Astrid Dempfle
Anna Schuster
Petra Wolf
Walter Hundt
Wolfgang Huber
spellingShingle Silke Steinbach
Wolfgang Reindl
Astrid Dempfle
Anna Schuster
Petra Wolf
Walter Hundt
Wolfgang Huber
Smell and taste in inflammatory bowel disease.
PLoS ONE
author_facet Silke Steinbach
Wolfgang Reindl
Astrid Dempfle
Anna Schuster
Petra Wolf
Walter Hundt
Wolfgang Huber
author_sort Silke Steinbach
title Smell and taste in inflammatory bowel disease.
title_short Smell and taste in inflammatory bowel disease.
title_full Smell and taste in inflammatory bowel disease.
title_fullStr Smell and taste in inflammatory bowel disease.
title_full_unstemmed Smell and taste in inflammatory bowel disease.
title_sort smell and taste in inflammatory bowel disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description OBJECTIVE: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. PATIENTS AND METHODS: In total, 59 IBD patients (37 Crohn's disease (CD) and 22 ulcerative colitis (UC) patients) were studied using "Sniffin' sticks" and "taste strips" for olfactory and gustatory tests, respectively, and compared to healthy controls and published normative data. RESULTS: Among IBD (CD and UC) patients, the values for odor threshold, but not for odor identification or discrimination, were significantly lower than that of the normative data. Further, these patients showed lower values than the normative taste values and the control group for all tastes, except sour; 57.6% of the IBD patients were hyposmic, while 30.5% were hypogeusic. Subjective self-assessments showed that the patients were not aware of their reduced olfactory/gustatory functions. There were no relevant differences in taste and smell abilities between the CD and UC patients. Disease activity and treatment did not influence the olfactory/gustatory functions. CONCLUSION: IBD (CD and UC) patients exhibited significant reductions in the olfactory and gustatory functions. Therefore, patients should be tested by smell/taste tests, in order to be adequately informed of their olfactory/gustatory functions and provided an understanding of how to overcome their limitations, and thus improve their quality of life.
url http://europepmc.org/articles/PMC3783456?pdf=render
work_keys_str_mv AT silkesteinbach smellandtasteininflammatoryboweldisease
AT wolfgangreindl smellandtasteininflammatoryboweldisease
AT astriddempfle smellandtasteininflammatoryboweldisease
AT annaschuster smellandtasteininflammatoryboweldisease
AT petrawolf smellandtasteininflammatoryboweldisease
AT walterhundt smellandtasteininflammatoryboweldisease
AT wolfganghuber smellandtasteininflammatoryboweldisease
_version_ 1725905368770412544